Naltrexone

CHEMBL19019 Phase 4 अनुमोदित Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

341.4 g/mol

LogP

1.9

Phase

4

This medication is used to help people who have stopped using opioids or alcohol from returning to these substances by blocking the pleasurable effects they would normally produce. It is taken daily as a tablet or given monthly as an injectable and works best as part of a comprehensive addiction treatment program.

आणविक भार

341.4000 g/mol

LogP

1.90

TPSA

70.00 Å²

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

HIV/एड्स अनिद्रा अल्ज़ाइमर रोग इंफ्लेमेटरी बाउल डिज़ीज़ उच्च रक्तचाप एटोपिक डर्मेटाइटिस (एक्जिमा) एंडोमेट्रियोसिस क्रॉनिक ऑब्सट्रक्टिव पल्मोनरी डिज़ीज़ (COPD) क्रॉनिक किडनी डिज़ीज़ क्षय रोग (ट्यूबरकुलोसिस) गैस्ट्रोइसोफेजियल रिफ्लक्स रोग टाइप 2 मधुमेह दर्द प्रबंधन दीर्घकालिक दर्द नॉन-अल्कोहलिक फैटी लिवर डिज़ीज़ पार्किंसन रोग प्रोस्टेट कैंसर बाइपोलर डिसऑर्डर मल्टीपल स्क्लेरोसिस माइग्रेन मेजर डिप्रेसिव डिसऑर्डर मेलानोमा मोटापा रुमेटॉइड आर्थराइटिस श्वसन रोग संक्रामक रोग सिज़ोफ्रेनिया सिस्टेमिक ल्यूपस एरिथेमेटोसस सोरायसिस स्तन कैंसर हृदय विफलता हृदय-संवहनी रोग

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5

InChI

InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1

Molecular Formula

C20H23NO4

HBD / HBA

2 / 5

घूर्णनीय बंधन

2

भारी परमाणु

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

This medication is used to help people who have stopped using opioids or alcohol from returning to these substances by blocking the pleasurable effects they would normally produce. It is taken daily as a tablet or given monthly as an injectable and works best as part of a comprehensive addiction treatment program.

Yes, Naltrexone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL19019. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5360515. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

रोगी-अनुकूल जानकारी खोज रहे हैं?

Naltrexone PillFYI पर

संरचना

त्वरित डेटा

सूत्र: C20H23NO4
पर्यायवाची: 2

बाहरी लिंक

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.